a developer of therapeutics to treat hepatitis and other infectious diseases, using human antibodies and synthetic chemicals
Industry Biotechnology
A.I.dvisor indicates that over the last year, XTLB has been loosely correlated with SER. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XTLB jumps, then SER could also see price increases.
| Ticker / NAME | Correlation To XTLB | 1D Price Change % | ||
|---|---|---|---|---|
| XTLB | 100% | -6.62% | ||
| SER - XTLB | 59% Loosely correlated | -3.27% | ||
| ADTX - XTLB | 27% Poorly correlated | -22.98% | ||
| BCLI - XTLB | 26% Poorly correlated | -3.89% | ||
| BCRX - XTLB | 25% Poorly correlated | -1.92% | ||
| CRNX - XTLB | 25% Poorly correlated | +1.63% | ||
More | ||||